Statements (33)
Predicate | Object |
---|---|
gptkbp:instanceOf |
psychedelic phenethylamine
|
gptkbp:belongs_to_class |
gptkb:2C_family
|
gptkbp:CASNumber |
207740-25-8
|
gptkbp:chemicalFormula |
C13H21NO2
|
gptkbp:color |
white
|
gptkbp:discoveredBy |
gptkb:Alexander_Shulgin
|
gptkbp:duration_of_effects |
10-20 hours
|
gptkbp:effect |
euphoria
hallucinations altered perception |
gptkbp:firstSynthesized |
1974
|
gptkbp:hasSMILES |
CCCNc1cc(OC)cc(OC)c1
|
gptkbp:hasStreet |
gptkb:2C-P
|
https://www.w3.org/2000/01/rdf-schema#label |
2C-P
|
gptkbp:IUPACName |
2-(4-propyl-2,5-dimethoxyphenyl)ethanamine
|
gptkbp:legalStatus |
gptkb:Schedule_III_(Canada)
gptkb:Class_A_(UK) Schedule I (USA) |
gptkbp:meltingPoint |
151-152°C
|
gptkbp:molecularWeight |
223.31 g/mol
|
gptkbp:PubChem_CID |
4527137
|
gptkbp:publishedIn |
gptkb:PiHKAL
|
gptkbp:relatedTo |
gptkb:2C-T-7
gptkb:2C-E gptkb:2C-B |
gptkbp:routeOfAdministration |
oral
insufflation |
gptkbp:solubility |
soluble in water
|
gptkbp:toxicity |
not well studied
|
gptkbp:UNII |
2ZK1V6F2F6
|
gptkbp:bfsParent |
gptkb:NBOMe_series
gptkb:2C_family |
gptkbp:bfsLayer |
7
|